Report overview
This report contains market size and forecasts of Biosimilar Testing and Development Services in Global, including the following market information:
Global Biosimilar Testing and Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilar Testing and Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Effector Binding Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilar Testing and Development Services include Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri and Pace Analytical Services and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilar Testing and Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Testing and Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, by Type, 2021 (%)
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Global Biosimilar Testing and Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, by Application, 2021 (%)
PK assay
Tiered Immunogenicity testing
NAb assays
Global Biosimilar Testing and Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar Testing and Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilar Testing and Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
